Medium chain triglycerides dose-dependently prevent liver pathology in a rat model of non-alcoholic fatty liver disease

2013 ◽  
Vol 238 (2) ◽  
pp. 151-162 ◽  
Author(s):  
Martin J J Ronis ◽  
January N Baumgardner ◽  
Neha Sharma ◽  
Jamie Vantrease ◽  
Matthew Ferguson ◽  
...  
2013 ◽  
Vol 12 (1) ◽  
Author(s):  
Hemda Schmilovitz-Weiss ◽  
Edith Hochhauser ◽  
Michal Cohen ◽  
Yelena Chepurko ◽  
Smadar Yitzhaki ◽  
...  

2013 ◽  
Vol 32 ◽  
pp. S170
Author(s):  
P. Jegatheesan ◽  
S. Beutheu ◽  
G. Ventura ◽  
A.-J. Waligora-Dupriet ◽  
N. Kapel ◽  
...  

2018 ◽  
Vol 7 (4) ◽  
pp. 664-680 ◽  
Author(s):  
James E. Klaunig ◽  
Xilin Li ◽  
Zemin Wang

Non-alcoholic fatty liver disease is a major cause of chronic liver pathology in humans.


2021 ◽  
pp. 1753495X2110347
Author(s):  
Charlotte S Benson ◽  
Jeremy F Cobbold ◽  
Charlotte J Frise

Non-alcoholic fatty liver disease (NAFLD) is now the commonest liver pathology in the UK; however, relatively little is known about its course in pregnancy or the effect it has on maternal or fetal outcomes. Described here is a 24-year-old woman in her first pregnancy who presented with non-specific symptoms and raised alanine aminotransferase with ultrasonography of her liver showing changes of steatosis and suspicious for cirrhosis, leading to a diagnosis of NAFLD. The case illustrates the need for the clinician to have awareness of this increasingly prevalent condition and for multidisciplinary management.


2012 ◽  
Vol 33 (6) ◽  
pp. 373-376 ◽  
Author(s):  
Yoshihiko Hirotani ◽  
Ayae Doi ◽  
Tomoki Takahashi ◽  
Hanako Umezawa ◽  
Yoko Urashima ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document